Anthony Petrone

Q: How accurate are Anthony Petrone's stock ratings?

About 60% of Anthony's ratings were profitable over a one-year hold, with an average return of +9.2% per rating, measured by 13Foresight from historical prices.

Q: How is Anthony ranked?

Anthony Petrone is ranked #626 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Mizuho Securities

Wall Street Analyst

★★★★☆

#626

on 13Foresight · ranked by our own returns

60%

Success Rate

+9.2%

Average Return

42 of 70 calls profitable · +4.1% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 60% of Anthony Petrone's ratings turned a profit when each position was held for 1 year — averaging +9.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

105 Buy 23 Hold 0 Sell

Anthony's Stock Coverage 42 ratings · 2026-08-12

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
PLSE Pulse Biosciences	Aug 10, 2026	BUY	Strong Buy -4.7% avg upside 5 analysts	$45.00 1.37% Upside	·	·
DXCM Dexcom	Aug 04, 2026	BUY	Strong Buy +19.0% avg upside 32 analysts	$95.00 6.05% Upside	+2.9%	·
INSP Inspire Medical Systems	Aug 04, 2026	BUY	Buy +42.9% avg upside 21 analysts	$65.00 9.89% Upside	-9.1%	·
AXGN AxoGen	Jul 31, 2026	BUY	Strong Buy -27.4% avg upside 21 analysts	$58.00 19.55% Upside	+17.7%	·
GEHC GE Healthcare Technologies Inc	Jul 31, 2026	BUY	Strong Buy +13.0% avg upside 22 analysts	$85.00 16.76% Upside	+6.3%	·
GKOS Glaukos	Jul 31, 2026	BUY	Strong Buy -8.3% avg upside 21 analysts	$185.00 1.70% Upside	+6.6%	·
BSX Boston Scientific	Jul 31, 2026	BUY	Strong Buy +32.8% avg upside 38 analysts	$60.00 17.21% Upside	+5.5%	·
LNTH Lantheus	Jul 29, 2026	BUY	Buy -18.2% avg upside 21 analysts	$115.00 14.27% Upside	+0.6%	·
NPCE NeuroPace	Jul 28, 2026	BUY	Strong Buy +20.8% avg upside 13 analysts	$22.00 46.16% Upside	-3.3%	·
FOCL EDAP TMS	Jul 17, 2026	BUY	Buy +37.2% avg upside 8 analysts	$15.00 149.65% Upside	+14.3%	·
ADMA ADMA Biologics	Jul 15, 2026	BUY	Strong Buy +10.9% avg upside 15 analysts	$17.00 71.71% Upside	+12.3%	·
EW Edwards Lifesciences	Jul 15, 2026	BUY	Strong Buy +7.8% avg upside 34 analysts	$105.00 12.14% Upside	+6.8%	·
LIVN LivaNova	Jul 15, 2026	BUY	Strong Buy +4.4% avg upside 15 analysts	$95.00 20.80% Upside	-3.2%	·
SENS Senseonics Holdings	Jul 15, 2026	BUY	Buy +90.2% avg upside 13 analysts	$18.00 128.67% Upside	+36.3%	·
ESTA Establishment Labs Holdings	Jul 15, 2026	BUY	Strong Buy +20.0% avg upside 12 analysts	$105.00 41.39% Upside	-18.2%	·
CH:ALC Alcon	Jul 15, 2026	BUY	Buy +18.5% avg upside 35 analysts	$64.70 5.87% Upside	-0.9%	·
TNDM Tandem Diabetes Care	Jul 15, 2026	HOLD	Buy +39.8% avg upside 29 analysts	$20.00 14.63% Downside	+50.0%	·
TFX Teleflex	Jul 15, 2026	HOLD	Buy +38.4% avg upside 20 analysts	$145.00 8.56% Upside	+1.4%	·
RMD Resmed	Jul 15, 2026	BUY	Buy +2.2% avg upside 27 analysts	$220.00 2.16% Downside	+6.7%	·
ISRG Intuitive Surgical	Jul 15, 2026	HOLD	Strong Buy +19.9% avg upside 36 analysts	$400.00 0.38% Downside	+3.2%	·
HAE Haemonetics	Jul 15, 2026	BUY	Buy -13.7% avg upside 17 analysts	$90.00 3.21% Upside	+14.5%	·
MDT Medtronic	Jun 03, 2026	BUY	Buy +6.9% avg upside 38 analysts	$100.00 10.29% Upside	+15.9%	·
MMED MiniMed Group, Inc.	Jun 03, 2026	BUY	Strong Buy +12.2% avg upside 14 analysts	$21.00 6.18% Upside	+37.5%	·
COO Cooper Co	Jun 03, 2026	BUY	Buy +75.0% avg upside 21 analysts	$85.00 10.68% Upside	+23.0%	·
STAA Staar Surgical	May 14, 2026	HOLD	Hold +35.4% avg upside 16 analysts	$27.00 8.33% Upside	-22.1%	·
MNKD MannKind	May 07, 2026	BUY	Buy +82.2% avg upside 22 analysts	$7.00 82.22% Upside	+10.1%	·
EMBC Embecta Corporation	May 06, 2026	HOLD	Hold +104.9% avg upside 5 analysts	$5.00 2.38% Upside	+42.2%	·
MDXG MiMedx Group	Apr 30, 2026	BUY	Strong Buy +148.5% avg upside 17 analysts	$8.00 85.19% Upside	+27.4%	·
ABT Abbott Laboratories	Apr 20, 2026	HOLD	Strong Buy +5.2% avg upside 36 analysts	$115.00 4.87% Upside	+14.0%	·
TEM Tempus AI, Inc. Class A	Apr 13, 2026	BUY	Buy +17.8% avg upside 21 analysts	$100.00 79.49% Upside	+19.8%	·
GH Guardant Health	Jun 13, 2025	BUY	Strong Buy -1.1% avg upside 31 analysts	$65.00 60.59% Downside	+167.0%	·
ZBH Zimmer Biomet Holdings	Nov 05, 2021	BUY	Buy +17.5% avg upside 38 analysts	$175.00 79.90% Upside	-23.1%	·
LMAT Lemaitre Vascular	Sep 16, 2021	BUY	Strong Buy +22.2% avg upside 15 analysts	$70.00 15.58% Downside	-14.1%	·
TELA TELA Bio	Aug 11, 2021	BUY	Strong Buy +956.3% avg upside 8 analysts	$20.00 2431.65% Upside	-37.6%	·
TARS Tarsus Pharmaceuticals	Aug 10, 2021	BUY	Strong Buy +12.7% avg upside 16 analysts	$45.00 35.31% Downside	-29.1%	·
IART Integra Lifesciences	May 20, 2021	BUY	Buy +150.1% avg upside 21 analysts	$86.00 395.10% Upside	-15.6%	·
CTSO Cytosorbents	Sep 17, 2020	BUY	Strong Buy +3181.7% avg upside 13 analysts	$15.00 4066.70% Upside	+0.0%	·
VREX Varex Imaging	Aug 13, 2020	HOLD	Hold +21.4% avg upside 9 analysts	$18.00 3.03% Downside	+115.0%	·
VRAYQ Viewray	Dec 03, 2019	BUY	Strong Buy +558333233.3% avg upside 12 analysts	$7.00 699999899.94% Upside	·	·
ARAY Accuray	Aug 17, 2018	BUY	Buy +2043.0% avg upside 9 analysts	$6.00 1971.03% Upside	-27.1%	·
OSIS OSI Systems	Aug 25, 2017	BUY	Strong Buy -1.9% avg upside 11 analysts	$93.00 60.03% Downside	-8.6%	·
PRGO Perrigo Company	Aug 02, 2016	HOLD	Buy +431.9% avg upside 20 analysts	$97.00 654.84% Upside	-20.7%	·

🔒 37 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Anthony Petrone — Frequently Asked Questions

How accurate are Anthony Petrone's stock ratings?

Based on the calls 13Foresight could measure, about 60% of Anthony's ratings were profitable over a one-year hold, with an average return of +9.2% per rating, or +4.1% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Anthony ranked on 13Foresight?

Anthony Petrone is currently ranked #626 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Anthony cover?

Anthony most recently has ratings on PLSE, DXCM, INSP, AXGN, GEHC, GKOS, BSX, LNTH, NPCE, FOCL, ADMA, EW and 30 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Anthony Petrone

Rating Distribution

Welcome to 13Foresight!